Edesa Biotech, Inc. (EDSA) vs Scilex Holding Company (SCLX)
A side-by-side comparison of Edesa Biotech, Inc. and Scilex Holding Company across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
EDSA
Edesa Biotech, Inc.
$3.72HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
SCLX
Scilex Holding Company
$3.96HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — EDSA vs SCLX
growth of $100 · dividends reinvested · last 6yEDSA -89.1% (-30.9%/yr)SCLX -98.9% (-52.8%/yr)EDSA compounded faster over this window
Log scale — wide-divergence pair
EDSA SCLX
EDSA vs SCLX: by the numbers
- •EDSA is the larger company ($36M vs $34M market cap).
- •Both run net losses; EDSA's is the smaller (0.00% vs -1414.57% net margin).
Metrics side by side
Valuation
| Metric | EDSA | SCLX |
|---|---|---|
| P/S ratio | N/A | 1.06 |
| P/B ratio | 89.82 | N/A |
Profitability
| Metric | EDSA | SCLX |
|---|---|---|
| Gross margin | 0.00% | 49.68% |
| Operating margin | 0.00% | -903.52% |
| Net margin | 0.00% | -1414.57% |
| ROE | -160.05% | N/A |
| ROIC | -166.02% | N/A |
Growth (annualized)
| Metric | EDSA | SCLX |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 3.58% |
| Total return CAGR (5Y) | -39.88% | -59.50% |
Frequently asked
- How have EDSA and SCLX total returns compared?
- Over the past 5 years, EDSA delivered -39.88% and SCLX delivered -59.50% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.